Johnson & Johnson's nipocalimab receives FDA Fast Track status for Sjögren's disease, following strong Phase 2 trial results on disease activity and IgG reduction.

Johnson & Johnson's nipocalimab earns FDA Fast Track status for Sjögren's disease, speeding development and review for unmet medical needs.

ABSTRACT: Objective: To explore the application effect of clinical nursing pathway (CNP) in the perioperative period of labial glands biopsy for patients with Sjögren’s syndrome. Methods: A total of ...

There are two main types of pancreatic cancers—those that start in the exocrine gland and those that start in the endocrine cells. Pancreatic cancer is a rare, but deadly disease. Treatment options ...

Gland Pharma Ltd on Tuesday (February 25) announced that America's drug regulatory watchdog has completed a crucial inspection of its Andhra Pradesh facility. In a regulatory filing, Gland Pharma said ...

Shares of Gland Pharma gained about 5 percent on February 25, clocking its best day in 16 weeks, ahead of its investor meet on Feb 27-28 during the analyst day with Emkay and BoB Capital.

Objective: To verify the effect of triamcinolone acetonide (TA) and major salivary glands saline irrigation on relieving xerostomia in Sjögren’s syndrome (SS) patients. Methods: The enrolled 49 SS ...

Pilocarpine induced saliva secretion was determined every 8 days. Submandibular glands (SMG) and lungs were harvested for the detection of pathological changes. We found that intratracheal ...